Department of Medicine 3 – Rheumatology and Immunology

Mutual Amplification of GLI2/Hedgehog and Transcription Factor JUN/AP-1 Signaling in Fibroblasts in Systemic Sclerosis: Potential Implications for Combined Therapies (2024) Bergmann C, Chenguiti Fakhouri S, Trinh-Minh T, Filla T, Rius Rigau AR, Ekici AB, Merlevede B, et al. Journal article Correction to: Back on track – digital health applications to treat back pain of rheumatic patients? Results of a qualitative interview study (Rheumatology International, (2024), 10.1007/s00296-024-05726-x) (2024) Boy K, May S, Labinsky H, Morf H, Heinze M, Leipe J, Kuhn S, et al. Journal article, Erratum CAR T cells in autoimmune disease: On the road to remission (2024) Schett G, June CH Journal article Polyol pathway-generated fructose is indispensable for growth and survival of non-small cell lung cancer (2024) Schwab A, Siddiqui MA, Ramesh V, Gollavilli PN, Turtos AM, Møller SS, Pinna L, et al. Journal article Successful generation of fully human, second generation, anti-CD19 CAR T cells for clinical use in patients with diverse autoimmune disorders (2024) Mougiakakos D, Sengupta R, Gold R, Schroers R, Haghikia A, Lorente M, Pendleton M, et al. Journal article Correlation of changes in inflammatory and collagen biomarkers with durable guselkumab efficacy through 2 years in participants with active psoriatic arthritis: results from a phase III randomized controlled trial (2024) Siebert S, Schett G, Raychaudhuri SP, Guma M, Chen W, Gao S, Chakravarty SD, et al. Journal article Metabolic rewiring controlled by HIF-1α tunes IgA-producing B-cell differentiation and intestinal inflammation (2024) Meng X, Asadi Asadabad S, Cao S, Song R, Lin Z, Safhi M, Qin Y, et al. Journal article Comment on: Rescue therapy of anti-synthetase syndrome with CD19-targeted CART cells after failure of several B cell-depleting antibodies: reply. (2024) Taubmann J, Knitza J, Müller F, Völkl S, Aigner M, Kretschmann S, Atzinger A, et al. Journal article Correction to: Collating the voice of people with autoimmune diseases: Methodology for the third phase of the COVAD studies (2024) Kadam E, Javaid M, Sen P, Saha S, Ziade N, Day J, Wincup C, et al. Journal article, Erratum Baricitinib as monotherapy for treatment of rheumatoid arthritis: analysis of real-world data (2024) Edwards CJ, Takeuchi T, Finckh A, Kleyer A, Haladyj E, Gerwien JG, Treuer T, et al. Journal article, Review article